Stockreport

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation [Yahoo! Finance]

Inhibrx Biosciences, Inc.  (INBX) 
PDF programs in ongoing clinical trials and a strong emerging pipeline, is pleased to announce a decisive legal victory in a trade secrets case brought by I-Mab Biopharma (" [Read more]